Y. M. Rustum

540 total citations
21 papers, 449 citations indexed

About

Y. M. Rustum is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Y. M. Rustum has authored 21 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Y. M. Rustum's work include Colorectal Cancer Treatments and Studies (13 papers), Cancer Treatment and Pharmacology (6 papers) and Gastric Cancer Management and Outcomes (4 papers). Y. M. Rustum is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Cancer Treatment and Pharmacology (6 papers) and Gastric Cancer Management and Outcomes (4 papers). Y. M. Rustum collaborates with scholars based in United States, Germany and Greece. Y. M. Rustum's co-authors include A. Harstrick, Zhenggang Zhang, Shousong Cao, Jessie L.‐S. Au, Judith S. Walker, E. Mayhew, D. Papahadjopoulos, C. Anthony Hunt, David P. Baccanari and C Frank and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Pharmacology and Experimental Therapeutics and Drug Metabolism and Disposition.

In The Last Decade

Y. M. Rustum

20 papers receiving 419 citations

Peers

Y. M. Rustum

ONCOL

PRM

PFM

BIOMA

K Csóka Sweden

Peter Nygren Sweden

Corbett Th

W J van der Vijgh Netherlands

A Krikorian France

Sikic Bi United States

Joanna Regis United States

J. H. M. Schellens Netherlands

T. L. Loo United States

JHM Schellens Netherlands

K Csóka Sweden

Y. M. Rustum

207 ×0.8

ONCOL

246 ×1.4

47 ×0.6

PRM

42 ×0.6

PFM

24 ×0.6

BIOMA

Citations per year, relative to Y. M. Rustum Y. M. Rustum (= 1×) peers K Csóka

Countries citing papers authored by Y. M. Rustum

Since Specialization

Citations

This map shows the geographic impact of Y. M. Rustum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. M. Rustum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. M. Rustum more than expected).

Fields of papers citing papers by Y. M. Rustum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. M. Rustum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. M. Rustum. The network helps show where Y. M. Rustum may publish in the future.

Co-authorship network of co-authors of Y. M. Rustum

This figure shows the co-authorship network connecting the top 25 collaborators of Y. M. Rustum. A scholar is included among the top collaborators of Y. M. Rustum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. M. Rustum. Y. M. Rustum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rustum, Y. M., Shousong Cao, Farukh A. Durrani, & Marwan Fakih. (2004). Se-(methyl)selenocysteine (MSC) potentiates the antitumor activity of irinotecan against human tumor xenografts and protects against drug induced toxicity. Journal of Clinical Oncology. 22(14_suppl). 2068–2068. 2 indexed citations

Hausheer, F. H., Peter M. Kanter, Shousong Cao, et al.. (1998). Modulation of platinum-induced toxicities and therapeutic index: mechanistic insights and first- and second-generation protecting agents.. PubMed. 25(5). 584–99. 46 indexed citations

Cao, Shousong, C Frank, Tetsuhiko Shirasaka, & Y. M. Rustum. (1995). 5-Fluorouracil prodrug: role of anabolic and catabolic pathway modulation in therapy of colorectal cancer.. PubMed. 1(8). 839–45. 29 indexed citations

Markowitz, Sanford D., James Lutterbaugh, Lois L. Myeroff, et al.. (1995). Mutant K-ras oncogenes in colon cancers Do not predict Patient's chemotherapy response or survival. PubMed. 1(4). 441–5. 26 indexed citations

Baccanari, David P., et al.. (1995). 5-Ethynyluracil (776C85): effects on the antitumor activity and pharmacokinetics of tegafur, a prodrug of 5-fluorouracil.. PubMed. 55(24). 6227–30. 19 indexed citations

Rustum, Y. M., et al.. (1994). MODULATION OF THE ANTITUMOR-ACTIVITY OF 5-FLUOROURACIL AND CISPLATINUM BY N-PHOSPHONACETYL-L-ASPARTATE IN THE MURINE COLON-CARCINOMA NUMBER-26. International Journal of Oncology. 5(5). 1065–8. 1 indexed citations

Spector, T, David Porter, Donald J. Nelson, et al.. (1994). 5-Ethynyluracil (776C85), a modulator of the therapeutic activity of 5-fluorouracil. Drugs of the Future. 19(6). 565–565. 40 indexed citations

Rustum, Y. M., et al.. (1994). THE COMBINED-ACTION OF ICI-D1694, 5-FLUORO-2'-DEOXYURIDINE AND 5-FLUOROURACIL IN INHIBITING THE GROWTH OF A HUMAN RENAL-CELL CARCINOMA CELL-LINE (RPMI-SE) IN-VITRO. International Journal of Oncology. 4(1). 137–41. 2 indexed citations

Schmoll, Hans‐Joachim, et al.. (1992). The emerging role for biomodulation of antineoplastic agents.. PubMed. 19(2 Suppl 3). 1–3. 5 indexed citations

10.

Yin, Ming, et al.. (1992). Time dependence of DNA lesions and growth inhibition by ICI D1694, a new quinazoline antifolate thymidylate synthase inhibitor.. PubMed. 52(21). 5900–5. 31 indexed citations

11.

Zhang, Zhenggang, A. Harstrick, & Y. M. Rustum. (1992). Modulation of fluoropyrimidines: role of dose and schedule of leucovorin administration.. PubMed. 19(2 Suppl 3). 10–5. 37 indexed citations

12.

Zhang, Zhenggang, A. Harstrick, & Y. M. Rustum. (1992). Mechanisms of resistance to fluoropyrimidines.. PubMed. 19(2 Suppl 3). 4–9. 36 indexed citations

13.

Etiévant, Chantal, Jérôme Cros, & Y. M. Rustum. (1990). New Concepts in Cancer.

14.

Rustum, Y. M.. (1990). Biochemical Rationale for the 5-Fluorouracil Leucovorin Combination and Update of Clinical Experience. Journal of Chemotherapy. 2(sup1). 5–11. 12 indexed citations

15.

Adelstein, David J., et al.. (1987). Bioavailability of high-dose oral leucovorin.. PubMed. 57–60. 9 indexed citations

16.

Zittoun, R, J Zittoun, J Marquet, Y. M. Rustum, & Patrick J. Creaven. (1985). Modulation of 1-beta-D-arabinofuranosylcytosine metabolism by thymidine in human acute leukemia.. PubMed. 45(10). 5186–92. 10 indexed citations

17.

Au, Jessie L.‐S., Judith S. Walker, & Y. M. Rustum. (1983). Pharmacokinetic studies of 5-fluorouracil and 5'-deoxy-5-fluorouridine in rats.. Journal of Pharmacology and Experimental Therapeutics. 227(1). 174–180. 50 indexed citations

18.

Ellens, Harma, Y. M. Rustum, E. Mayhew, & Elihu J. Ledesma. (1982). Distribution and metabolism of lipsome-encapsulated and free 1-beta-D-arabinofuranosylcytosine (Ara-C) in dog and mouse tissues.. Journal of Pharmacology and Experimental Therapeutics. 222(2). 324–330. 10 indexed citations

19.

Rustum, Y. M., et al.. (1982). Relationship between plasma Ara-C and intracellular Ara-CTP pools under conditions of continuous infusion and high-dose Ara-C treatment. Medical and Pediatric Oncology. 10(S1). 33–43. 21 indexed citations

20.

Hunt, C. Anthony, Y. M. Rustum, E. Mayhew, & D. Papahadjopoulos. (1979). Retention of cytosine arabinoside in mouse lung following intravenous administration in liposomes of different size.. Drug Metabolism and Disposition. 7(3). 124–128. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact